European Heart Journal Advance Access published online on November 30, 2004
European Heart Journal, doi:10.1093/eurheartj/ehi020
Copyright © 2004 by the European Society of Cardiology.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cardiology, Heart-Lung Centre Utrecht, Utrecht, The Netherlands
* To whom correspondence should be addressed. The incidence of cardiac failure and chronic renal failure is increasing and it has now become clear that the co-existence of the two problems has an extremely bad prognosis. We propose the severe cardiorenal syndrome (SCRS), a pathophysiological condition in which combined cardiac and renal dysfunction amplifies progression of failure of the individual organ, so that cardiovascular morbidity and mortality in this patient group is at least an order of magnitude higher than in the general population. Guyton has provided an excellent framework describing the physiological relationships between cardiac output, extracellular fluid volume control, and blood pressure. While this model is also sufficient to understand systemic haemodynamics in combined cardiac and renal failure, not all aspects of the observed accelerated atherosclerosis, structural myocardial changes, and further decline of renal function can be explained. Since increased activity of the renin-angiotensin system, oxidative stress, inflammation, and increased activity of the sympathetic nervous system seem to be cornerstones of the pathophysiology in combined chronic renal disease and heart failure, we have explored the potential interactions between these cardiorenal connectors. As such, the cardiorenal connection is an interactive network with positive feedback loops, which, in our view, forms the basis for the SCRS.
Review
The severe cardiorenal syndrome: Guyton revisited
2 Department of Nephrology and Hypertension F03.226, University Medical Centre Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands
Branko Braam, E-mail: obeloqui{at}unav.es
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Damman, T. Jaarsma, A. A. Voors, G. Navis, H. L. Hillege, D. J. van Veldhuisen, and on behalf of the COACH investigators Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH) Eur J Heart Fail, September 1, 2009; 11(9): 847 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. van der Putten, L. G. Bongartz, B. Braam, and C. A.J.M. Gaillard The cardiorenal syndrome a classification into 4 groups? J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1340 - 1340. [Full Text] [PDF] |
||||
![]() |
C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo Reply J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1340 - 1341. [Full Text] [PDF] |
||||
![]() |
A. Kazory and E. A. Ross Anemia: the point of convergence or divergence for kidney disease and heart failure? J. Am. Coll. Cardiol., February 24, 2009; 53(8): 639 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Campbell, X. Sui, G. Filippatos, T. E. Love, C. Wahle, P. W. Sanders, and A. Ahmed Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study Nephrol. Dial. Transplant., January 1, 2009; 24(1): 186 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. McMurray, M. Petrie, K. Swedberg, M. Komajda, S. Anker, and R. Gardner CHAPTER 23 Heart Failure ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo Cardiorenal Syndrome J. Am. Coll. Cardiol., November 4, 2008; 52(19): 1527 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. K. M. Windt, R. H. Henning, A. C. A. Kluppel, Y. Xu, D. de Zeeuw, and R. P. E. van Dokkum Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3103 - 3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Amsalem, M. Garty, R. Schwartz, A. Sandach, S. Behar, A. Caspi, S. Gottlieb, D. Ezra, B. S. Lewis, and J. Leor Prevalence and significance of unrecognized renal insufficiency in patients with heart failure Eur. Heart J., April 2, 2008; 29(8): 1029 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R.J. van Kimmenade, Y. Pinto, and J. L. Januzzi Jr When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the 'cardio-renal syndrome'? Eur. Heart J., December 2, 2007; 28(24): 2960 - 2961. [Full Text] [PDF] |
||||
![]() |
V. Hasselblad, W. G. Stough, M. R. Shah, Y. Lokhnygina, C. M. O'Connor, R. M. Califf, and K. F. Adams Jr. Relation between dose of loop diuretics and outcomes in a heart failure population: Results of the ESCAPE Trial Eur J Heart Fail, October 1, 2007; 9(10): 1064 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-S. Spanaus, F. Kronenberg, E. Ritz, R. Schlapbach, D. Fliser, M. Hersberger, B. Kollerits, P. Konig, A. von Eckardstein, and for the Mild-to-Moderate Kidney Disease Study Grou B-Type Natriuretic Peptide Concentrations Predict the Progression of Nondiabetic Chronic Kidney Disease: The Mild-to-Moderate Kidney Disease Study Clin. Chem., July 1, 2007; 53(7): 1264 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ng Kam Chuen and R. J MacFadyen Variable aetiologies contributing to the anaemia of systolic heart failure are important to individual patient management Eur. Heart J., January 2, 2007; 28(2): 143 - 145. [Full Text] [PDF] |
||||
![]() |
K. E. Jie, M. C. Verhaar, M.-J. M. Cramer, K. van der Putten, C. A. J. M. Gaillard, P. A. Doevendans, H. A. Koomans, J. A. Joles, and B. Braam Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors Am J Physiol Renal Physiol, November 1, 2006; 291(5): F932 - F944. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A.K.M. Windt, W. B.A. Eijkelkamp, R. H. Henning, A. C.A. Kluppel, P. A. de Graeff, H. L. Hillege, S. Schafer, D. de Zeeuw, and R. P.E. van Dokkum Renal Damage after Myocardial Infarction Is Prevented by Renin-Angiotensin-Aldosterone-System Intervention J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3059 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R.J. van Kimmenade, J. L. Januzzi Jr, A. L. Baggish, J. G. Lainchbury, A. Bayes-Genis, A. M. Richards, and Y. M. Pinto Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure: Redefining the Cardiorenal Interaction? J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1621 - 1627. [Abstract] [Full Text] [PDF] |
||||







